Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013
Filters: Author is Mostaghel, Elahe A [Clear All Filters]
Androgen action and metabolism in prostate cancer.. Molecular and cellular endocrinology.. 2012.
Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion.. Nature clinical practice. Urology. 6(2):76-85.. 2009.
Prostate tissue androgens: history and current clinical relevance.. Urology. 72(2):247-54.. 2008.
Genomic strategy for targeting therapy in castration-resistant prostate cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(12):2022-9.. 2009.
Testosterone regulates tight junction proteins and influences prostatic autoimmune responses.. Hormones & cancer. 2(3):145-56.. 2011.
Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.. Cancer research. 68(11):4447-54.. 2008.
Impact of Male Hormonal Contraception on Prostate Androgens and Androgen Action in Healthy Men: A Randomized, Controlled Trial.. The Journal of clinical endocrinology and metabolism.. 2012.
New hormonal therapies for castration-resistant prostate cancer.. Endocrinology and metabolism clinics of North America. 40(3):625-42,x.. 2011.
Castration-resistant prostate cancer: targeting androgen metabolic pathways in recurrent disease.. Urologic oncology. 27(3):251-7.. 2009.
SLCO Transport Genes in Prostate Cancer--Response.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(10):2326-7.. 2011.
Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implications.. Best practice & research. Clinical endocrinology & metabolism. 22(2):243-58.. 2008.
Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(18):5913-25.. 2011.
Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial.. The Journal of clinical endocrinology and metabolism. 96(2):430-7.. 2011.
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.. The Journal of clinical investigation. 120(8):2715-30.. 2010.
Development, validation and application of a stable isotope dilution liquid chromatography electrospray ionization/selected reaction monitoring/mass spectrometry (SID-LC/ESI/SRM/MS) method for quantification of keto-androgens in human serum.. The Journal of steroid biochemistry and molecular biology. 138C:281-289.. 2013.
Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression.. Cancer research. 69(24):9448-56.. 2009.
Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(4):619-27.. 2011.
Doing Business with Arnold Library
Weintraub Building, B1-010
More About Arnold Library
- Information for Grant Writers
- Arnold Library News
- Affiliations and Memberships
- Journals List
- Web of Science - Science Citation Index
- Pubmed (Get Article Enabled)
- Library Catalog
- Document Delivery Form
- Center-Authored Papers
- Institutional Repository
- Researcher Profiles